PRESS RELEASE published on 02/25/2026 at 18:00, 3 months 24 days ago THX Pharma annonce l'augmentation des moyens affectés au contrat de liquidité THX Pharma augmente les moyens du contrat de liquidité confié à Portzamparc - BNP Paribas. Details des apports en titre et en espèces. Presentation de la société et de ses projets dans les maladies neurologiques rares. Contacts et déclarations prospectives Contrat De Liquidité Déclarations Prospectives Industrie Pharmaceutique Maladies Neurologiques Rares THX Pharma
BRIEF published on 02/19/2026 at 18:05, 4 months 2 days ago THX Pharma annonce une solide trésorerie en fin d'année THX Pharma Position De Trésorerie Accord Biocodex Programme Batten-1 Développement TX01
BRIEF published on 02/19/2026 at 18:05, 4 months 2 days ago THX Pharma Announces Strong Cash Position at Year-End Cash Position THX Pharma Biocodex Agreement Batten-1 Program TX01 Development
BRIEF published on 02/19/2026 at 18:05, 4 months 2 days ago THX Pharma renforce sa position financière au 31 décembre 2025 Partenariat Trésorerie Batten-1 TX01 Biocodex
BRIEF published on 02/19/2026 at 18:05, 4 months 2 days ago THX Pharma strengthens its financial position as of December 31, 2025 Treasury Partnership Batten-1 TX01 Biocodex
PRESS RELEASE published on 02/19/2026 at 18:00, 4 months 2 days ago THX Pharma publie sa position de trésorerie au 31 décembre 2025 THX Pharma annonce une trésorerie disponible de 7,764 k€ au 31 décembre 2025, renforcée par un accord avec Biocodex pour un versement de 12 M€ en mars 2026. Prochaine publication : Résultats financiers annuels le 28 avril 2026 Résultats Financiers Trésorerie Accord THX Pharma Biocodex
PRESS RELEASE published on 02/19/2026 at 18:00, 4 months 2 days ago THX Pharma Reports Its Cash Position as of December 31, 2025 THX Pharma (Theranexus) announces cash position of €7.8 million as of Dec 31, 2025. Pro forma cash position reaches €21.7 million with incoming payment from Biocodex agreement. Company focused on rare neurological diseases treatments development Cash Position Rare Neurological Diseases Therapeutic Solutions THX Pharma Biocodex Agreement
BRIEF published on 02/12/2026 at 18:05, 4 months 9 days ago THX Pharma annonce un webinaire sur son accord stratégique avec Biocodex Webinaire Accord Stratégique Batten-1 THX Pharma Biocodex
BRIEF published on 02/12/2026 at 18:05, 4 months 9 days ago THX Pharma and Biocodex conclude a major strategic agreement Webinar Strategic Agreement THX Pharma Neurological Medications Biocodex
BRIEF published on 02/12/2026 at 18:05, 4 months 9 days ago THX Pharma et Biocodex concluent un accord stratégique majeur Webinaire Accord Stratégique THX Pharma Médicaments Neurologiques Biocodex
Published on 06/20/2026 at 01:00, 2 days 5 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 days 6 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 3 days 2 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 3 days 5 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/22/2026 at 06:05, 35 minutes ago adidas and GLO Brands B.V., debuts ADIDAS PRO WORK, a new safety footwear range, combining performance, protection and style for the modern worksite
Published on 06/22/2026 at 04:05, 2 hours 35 minutes ago Optro Accelerates Global Growth with Singapore Hub, Delivering Agentic GRC to APAC Enterprises
Published on 06/20/2026 at 21:25, 1 day 9 hours ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 2 days ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 2 days 10 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 19:33, 2 days 11 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 11 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 11 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 2 days 11 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026